135 related articles for article (PubMed ID: 37088135)
61. Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR.
Yoshida R; Sasaki T; Umekage Y; Tanno S; Ono Y; Ogata M; Chiba S; Mizukami Y; Ohsaki Y
BMC Cancer; 2018 Nov; 18(1):1136. PubMed ID: 30453899
[TBL] [Abstract][Full Text] [Related]
62. CXCR4 mutations in lymphoplasmacytic lymphoma lead to altered CXCR4 expression.
Hiemcke-Jiwa LS; Leguit RJ; Jiwa NM; Huibers MMH; Minnema MC
Br J Haematol; 2019 Jun; 185(5):966-969. PubMed ID: 30408147
[No Abstract] [Full Text] [Related]
63.
Guerrera ML; Tsakmaklis N; Xu L; Yang G; Demos M; Kofides A; Chan GG; Manning RJ; Liu X; Chen JG; Munshi M; Patterson CJ; Castillo JJ; Dubeau T; Gustine J; Carrasco RD; Arcaini L; Varettoni M; Cazzola M; Treon SP; Hunter ZR
Haematologica; 2018 Sep; 103(9):e408-e411. PubMed ID: 29599202
[No Abstract] [Full Text] [Related]
64. Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Xu L; Hunter ZR; Yang G; Cao Y; Liu X; Manning R; Tripsas C; Chen J; Patterson CJ; Kluk M; Kanan S; Castillo J; Lindeman N; Treon SP
Leukemia; 2014 Aug; 28(8):1698-704. PubMed ID: 24509637
[TBL] [Abstract][Full Text] [Related]
65. Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond.
Magierowicz M; Tomowiak C; Leleu X; Poulain S
Hematol Oncol Clin North Am; 2018 Oct; 32(5):753-763. PubMed ID: 30190015
[TBL] [Abstract][Full Text] [Related]
66.
Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
[No Abstract] [Full Text] [Related]
67. Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.
Treon SP; Gustine J; Meid K; Yang G; Xu L; Liu X; Demos M; Kofides A; Tsakmaklis N; Chen JG; Munshi M; Chan G; Dubeau T; Raje N; Yee A; O'Donnell E; Hunter ZR; Castillo JJ
J Clin Oncol; 2018 Sep; 36(27):2755-2761. PubMed ID: 30044692
[TBL] [Abstract][Full Text] [Related]
68. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract][Full Text] [Related]
69. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.
Jiménez C; Prieto-Conde MI; García-Álvarez M; Alcoceba M; Escalante F; Chillón MDC; García de Coca A; Balanzategui A; Cantalapiedra A; Aguilar C; Corral R; González-López T; Marín LA; Bárez A; Puig N; García-Mateo A; Gutiérrez NC; Sarasquete ME; González M; García-Sanz R
Ann Hematol; 2018 Mar; 97(3):475-484. PubMed ID: 29353304
[TBL] [Abstract][Full Text] [Related]
70. Waldenstrom macroglobulinemia: genetics dictates clinical course.
Lenz G
Blood; 2014 May; 123(18):2750-1. PubMed ID: 24786453
[TBL] [Abstract][Full Text] [Related]
71. [Exploring the detection of MYD88 mutation in patients with Waldenström macroglobulinemia by different methods and specimens].
Tao Y; Pan ZK; Wang S; Wang L; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2022 May; 43(5):388-392. PubMed ID: 35680596
[No Abstract] [Full Text] [Related]
72. New treatment strategies for Waldenström macroglobulinemia.
Moreno DF; de Larrea CF; Castillo JJ
Clin Adv Hematol Oncol; 2022 Aug; 20(8):506-515. PubMed ID: 36125957
[TBL] [Abstract][Full Text] [Related]
73. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
[TBL] [Abstract][Full Text] [Related]
74. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
[TBL] [Abstract][Full Text] [Related]
75.
Gustine JN; Xu L; Tsakmaklis N; Demos MG; Kofides A; Chen JG; Liu X; Munshi M; Guerrera ML; Chan GG; Patterson CJ; Keezer A; Meid K; Dubeau T; Yang G; Hunter ZR; Treon SP; Castillo JJ
Blood Adv; 2019 Oct; 3(19):2800-2803. PubMed ID: 31570491
[No Abstract] [Full Text] [Related]
76. Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
Zanwar S; Abeykoon JP; Ansell SM; Gertz MA; Colby C; Larson D; Paludo J; He R; Warsame R; Greipp PT; King RL; Thompson CA; Witzig TE; Lacy MQ; Gonsalves W; Nowakowski GS; Dingli D; Go RS; Habermann TM; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
Br J Haematol; 2021 Oct; 195(2):210-216. PubMed ID: 34340248
[TBL] [Abstract][Full Text] [Related]
77. Enhanced ratio of signals enables digital mutation scanning for rare allele detection.
Castellanos-Rizaldos E; Paweletz C; Song C; Oxnard GR; Mamon H; Jänne PA; Makrigiorgos GM
J Mol Diagn; 2015 May; 17(3):284-92. PubMed ID: 25772705
[TBL] [Abstract][Full Text] [Related]
78. CXCR4-targeted PET imaging using
Muz B; Bandara N; Mpoy C; Sun J; Alhallak K; Azab F; Rogers BE; Azab AK
Cancer Biol Ther; 2020; 21(1):52-60. PubMed ID: 31571524
[No Abstract] [Full Text] [Related]
79. Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients.
Sklavenitis-Pistofidis R; Capelletti M; Liu CJ; Reidy M; Zavidij O; Huynh D; Henrick P; Savell A; Reyes K; Rivotto B; Bustoros M; Perilla-Glen A; Trippa L; Castillo JJ; Treon SP; Ghobrial IM
Blood; 2018 Dec; 132(24):2608-2612. PubMed ID: 30366921
[No Abstract] [Full Text] [Related]
80. SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.
Thomas SK
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):347-355. PubMed ID: 34980578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]